| Financial Year |
March 31 2023 |
| Monetary Funds |
1,809,137,242.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
166,582,788.93 |
| Accounts Receivable |
1,052,032,268.97 |
| Advances to Suppliers |
167,724,073.26 |
| Other Receivables |
528,212,531.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,017,805.95 |
| Inventories |
714,409,924.83 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
79,153,559.32 |
| Total Current Assets |
4,518,783,283.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
258,700,630.49 |
| Investment Properties |
57,314,499.47 |
| Fixed Assetes |
1,706,858,600.64 |
| Under-construction Projects |
91,803,555.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
195,673,672.93 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
68,022,750.12 |
| Deferred Income Tax Assets |
111,447,286.28 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,136,187,725.24 |
| Total Assets |
7,654,971,008.27 |
| Short-Term Loans |
72,652,101.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,255,230.50 |
| Accounts Payable |
845,092,114.68 |
| Accounts Received In Advance |
33,829,662.79 |
| Employee Compensation Payable |
11,645,979.58 |
| Taxes Payable |
16,854,684.95 |
| Interest Payable |
152,802.21 |
| Dividend Payable |
23,118,489.68 |
| Other payables |
222,463,286.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,169,174.71 |
| Other Current Liabilities |
6,941,837.34 |
| Sub-Total of Current Liabilities |
1,462,521,851.57 |
| Long-term Loans |
150,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
70,455,005.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
691,563,764.22 |
| Total Liabilities |
2,154,085,615.79 |
| Paid-In Capital(Or Share Stock) |
1,028,492,944.00 |
| Capital Surplus |
2,302,426,702.95 |
| Surplus Reserve |
502,018,395.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,653,360,362.12 |
| Minority Stockholder's Interest |
4,179,027.36 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,496,706,365.11 |
| Owner's Equity（Stockholder's Equity） |
5,500,885,392.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,654,971,008.27 |
